Neurobiology of Aging
Volume 30, Issue 7 , Pages 1078-1090 , July 2009

A transgenic rat model of Alzheimer's disease with extracellular Aβ deposition

  • Dorothy G. Flood

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 610 738 6249; fax: +1 610 344 0065.
    • ,
  • Yin-Guo Lin
    • ,
  • Diane M. Lang

      Affiliations

    • Present address: Pfizer, Inc., Eastern Point Road, Groton, CT 06340, USA.
    • ,
  • Stephen P. Trusko
    • ,
  • James D. Hirsch

      Affiliations

    • Present address: Invitrogen-Molecular Probes, 29851 Willow Creek Road, Eugene, OR 97402, USA.
    • ,
  • Mary J. Savage

      Affiliations

    • Present address: Merck & Co., 770 Sumneytown Pike, West Point, PA 19486, USA.
    • ,
  • Richard W. Scott

      Affiliations

    • Present address: Polymedix, Inc., 170 N. Radnor Chester Road, Suite 300, Radnor, PA 19087, USA.
    • ,
  • David S. Howland

      Affiliations

    • Present address: High Q Foundation, 350 Seventh Avenue, New York, NY 10001, USA.

Received 5 June 2007 ,Revised 24 September 2007 ,Accepted 13 October 2007.

References 

  1. Annaert WG, Levesque L, Craessaerts K, Dierinck I, Snellings G, Westaway D, et al. Presenilin 1 controls γ-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons. J. Cell. Biol. 1999;147:277–294
  2. Bloom FE, Reilly JF, Redwine JM, Wu C-C, Young WG, Morrison JH. Mouse models of human neurodegenerative disorders. Requirements for medication development. Arch. Neurol. 2005;62:185–187
  3. Cai X-D, Golde TE, Younkin SG. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science. 1993;259:514–516
  4. Citron M, Oltersdorf T, Haass C, McConologue L, Hung AY, Seubert P, et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature. 1992;360:672–674
  5. Cummings BJ, Satou T, Head E, Milgram NW, Cole GM, Savage MJ, et al. Diffuse plaques contain C-terminal Aβ42 and not Aβ40: evidence from cats and dogs. Neurobiol. Aging. 1996;17:653–659
  6. Czech C, Lesort M, Tremp G, Terro F, Blanchard V, Schombert B, et al. Characterization of human presenilin 1 transgenic rats: increased sensitivity to apoptosis in primary neuronal cultures. Neuroscience. 1998;87:325–336
  7. Echeverria V, Ducatenzeiler A, Alhonen L, Janne J, Grant SM, Wandosell F, et al. Rat transgenic models with a phenotype of intracellular Aβ accumulation in hippocampus and cortex. J. Alz. Dis. 2004;6:209–219
  8. Echeverria V, Ducatenzeiler A, Dowd E, Jänne J, Grant SM, Szyf M, et al. Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the β-amyloid peptide intracellularly in hippocampal and cortical neurons. Neuroscience. 2004;129:583–592
  9. Falinska AM, Marshall VJ, Chapman PF. The effects of high-cholesterol diet on behavior and synaptic physiology in βAPP transgenic rats. Soc. Neurosci. Abstr. 2002;28:191.2
  10. Flood DG, Reaume AG, Dorfman KS, Lin Y-G, Lang DM, Trusko SP, et al. FAD mutant PS-1 gene-targeted mice: increased Aβ42 and Aβ deposition without APP overproduction. Neurobiol. Aging. 2002;23:335–348
  11. Flood DG, Reaume AG, Gruner JA, Hoffman EA, Hirsch JD, Lin Y-G, et al. Hindlimb motor neurons require Cu/Zn superoxide dismutase for maintenance of neuromuscular junctions. Am. J. Pathol. 1999;155:663–672
  12. Folkesson R, Malkiewicz K, Kloskowsk E, Nilsson T, Popova E, Bogdanovic N, et al. A transgenic rat expressing human APP with the Swedish Alzheimer's disease mutation. Biochem. Biophys. Res. Commun. 2007;358:777–782
  13. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 1996;373:523–528
  14. Giannakopoulos P, Silhol S, Jallageas V, Mallet J, Bons N, Bouras C, et al. Quantitative analysis of tau protein-immunoreactive accumulations and beta amyloid protein deposits in the cerebral cortex of the mouse lemur, Microcebus murinus. Acta Neuropathol. (Berl). 1997;94:131–139
  15. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 1997;20:154–159
  16. Hoesche C, Sauerwald A, Veh RW, Krippl B, Killimann MW. The 5′-flanking region of the rat synapsin I gene directs neuron-specific, and developmentally regulated reporter gene expression in transgenic mice. J. Biol. Chem. 1993;268:26494–26502
  17. Hogan B, Constantini F, Lacy E. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1986;
  18. Howland DS, Savage MS, Huntress FA, Wallace RE, Schwartz DA, Loh T, et al. Mutant and native human β-amyloid precursor proteins in transgenic mouse brain. Neurobiol. Aging. 1995;16:685–699
  19. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 1996;274:99–102
  20. Jankowsky JL, Savonenko A, Schilling G, Wang J, Xu G, Borchelt DR. Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development. Curr. Neurol. Neurosci. Rep. 2002;2:457–464
  21. Lopez EM, Bell KFS, Ribeiro-da-Silva A, Cuello AC. Early changes in neurons of the hippocampus and neocortex in transgenic rats expression intracellular human A-β. J. Alz. Dis. 2004;6:421–431
  22. Loring JF, Paszty C, Rose A, McIntosh TK, Murai H, Pierce JES, et al. Rational design of an animal model for Alzheimer's disease: introduction of multiple human genomic transgenes to reproduce AD pathology in a rodent. Neurobiol. Aging. 1996;17:173–182
  23. Marshall VJ, Hsiao KK, Chapman PF. The production of a rat model of Alzheimer's disease. Soc. Neurosci. Abstr. 1999;25:741.16
  24. Pybus R, Barnard E, Estibeiro P, Mullins J, MacLeod N. Enhanced long-term potentiation in the hippocampus of rats expressing mutant presenilin-1 is age related. Neurobiol. Dis. 2003;12:212–224
  25. Quon D, Wang Y, Catalano R, Scardina JM, Murakami K, Cordell B. Formation of β-amyloid protein deposits in brains of transgenic mice. Nature. 1991;352:239–241
  26. Ruiz-Opazo N, Kosik KS, Lopez LV, Bagamasbad P, Ponce LRB, Herrera VLM. Attenuated hippocampus-dependent learning and memory decline in transgenic TgAPPswe Fischer-344 rats. Mol. Med. 2004;10:36–44
  27. Sasahara M, Fries JW, Raines EW, Gown AM, Westrum LE, Frosch MP, et al. PDGF-β chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model. Cell. 1991;64:217–227
  28. Sasahara M, Sato H, IIhara K, Wang J, Chue CH, Takayama S, et al. Expression of platelet-derived growth factor β-chain in the mature rat brain and pituitary gland. Brain Res. Mol. Brain Res. 1995;32:63–74
  29. Savage MJ, Iqbal M, Loh T, Trusko SP, Scott R, Siman R. Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the β-amyloid precursor protein. Neuroscience. 1994;60:607–619
  30. Savage MJ, Lin Y-G, Ciallella JR, Flood DG, Scott RW. Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition. J. Neurosci. 2002;22:3376–3385
  31. Savage MJ, Trusko SP, Howland DS, Pinsker LR, Mistretta S, Reaume AG, et al. Turnover of amyloid β-protein in mouse brain and acute reduction of its level by phorbol ester. J. Neurosci. 1998;18:1743–1752
  32. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 1996;2:864–870
  33. Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron. 1991;6:487–498
  34. Selkoe DJ. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell. Biol. 1998;8:447–453
  35. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science. 2002;298:789–791
  36. Selkoe DJ, Bell DS, Podlisny MB, Price DL, Cork LC. Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science. 1987;235:873–877
  37. Siman R, Reaume AG, Savage MJ, Trusko S, Lin Y-G, Scott RW, et al. Presenilin-1 P264L knock-in mutation: differential effects on Aβ production, amyloid deposition, and neuronal vulnerability. J. Neurosci. 2000;20:8717–8726
  38. Spires TL, Hyman BT. Transgenic models of Alzheimer's disease: learning from animals. NeuroRx. 2005;2:423–437
  39. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold K-H, Mistl C, Rothacher S, et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. U.S.A. 1997;94:13287–13292
  40. Suzuki N, Cheung TT, Cai X-D, Odaka A, Otvos L, Eckman C, et al. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science. 1994;264:1336–1340
  41. Vercauteren FGG, Clerens S, Roy L, Hamel N, Arckens L, Vandesande F, et al. Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer's disease-linked mutations in amyloid precursor protein and presenilin 1. Mol. Brain Res. 2004;132:241–259

PII: S0197-4580(07)00407-1

doi: 10.1016/j.neurobiolaging.2007.10.006

Neurobiology of Aging
Volume 30, Issue 7 , Pages 1078-1090 , July 2009

Article Tools

* Image Usage & Resolution